KALV KalVista Pharmaceuticals, Inc.
Healthcare$26.81+0.07%ClosedMarket Cap: $1.43B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$28.67
Target (Median)
$27.00
Target Range
$27.00 - $32.00
Upside from current price: 6.9%
Rating Distribution
1 Strong Buy6 Buy6 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-01 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-04-30 | Needham | downgrade | Hold | Buy |
| 2026-03-26 | Stifel | maintain | Buy | Buy |
| 2026-03-26 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-25 | Needham | maintain | Buy | Buy |
| 2026-01-09 | Needham | maintain | Buy | Buy |
| 2026-01-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-04 | Needham | maintain | Buy | Buy |
| 2025-11-11 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-09-12 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Apr 30 | $-1.73 | $182.5M | 3 |
| Fri Dec 31 | $0.64 | $310.9M | 6 |
| Sun Apr 30 | $0.64 | $310.9M | 6 |
| Sun Dec 31 | $2.02 | $425.4M | 3 |